AARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.877200E-01
Normal-vs-Stage2
5.095000E-01
Normal-vs-Stage3
8.110600E-01
Normal-vs-Stage4
1.946010E-01
Stage1-vs-Stage2
8.376800E-01
Stage1-vs-Stage3
4.376600E-01
Stage1-vs-Stage4
3.547800E-01
Stage2-vs-Stage3
2.935200E-01
Stage2-vs-Stage4
3.945200E-01
Stage3-vs-Stage4
1.643240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.723800E-01
Normal-vs-AfricanAmerican
1.740430E-01
Normal-vs-Asian
7.275200E-01
Caucasian-vs-AfricanAmerican
7.586800E-01
Caucasian-vs-Asian
5.411700E-02
AfricanAmerican-vs-Asian
6.918100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.299200E-01
Normal-vs-Female
5.805400E-01
Male-vs-Female
1.082850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.848800E-01
Normal-vs-Age(41-60Yrs)
2.109800E-01
Normal-vs-Age(61-80Yrs)
5.974000E-01
Normal-vs-Age(81-100Yrs)
5.111000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.201000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.081400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.173800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.512650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.335800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.173000E-01
Normal-vs-Daily Drinker
6.893600E-01
Normal-vs-Weekly Drinker
8.315000E-01
Normal-vs-Occasional Drinker
2.415000E-01
Normal-vs-Social Drinker
3.799000E-01
Non Drinker-vs-Daily Drinker
7.216200E-01
Non Drinker-vs-Weekly Drinker
8.830200E-01
Non Drinker-vs-Occasional Drinker
1.792060E-02
Non Drinker-vs-Social Drinker
1.022400E-01
Daily Drinker-vs-Weekly Drinker
9.166000E-01
Daily Drinker-vs-Occasional Drinker
5.138400E-02
Daily Drinker-vs-Social Drinker
2.015200E-01
Weekly Drinker-vs-Occasional Drinker
1.297620E-01
Weekly Drinker-vs-Social Drinker
3.146000E-01
Occasional Drinker-vs-Social Drinker
6.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.168000E-01
Normal-vs-Grade 2
9.678300E-02
Normal-vs-Grade 3
1.178200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.875380E-01
Grade 1-vs-Grade 3
1.267550E-02
Grade 1-vs-Grade 4
2.168000E-01
Grade 2-vs-Grade 3
7.372100E-02
Grade 2-vs-Grade 4
9.678300E-02
Grade 3-vs-Grade 4
1.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.360000E-01
Normal-vs-NonDiabetic
5.365200E-01
Diabetic-vs-NonDiabetic
8.745200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.485000E-01
Normal-vs-NoPancreatitis
5.334200E-01
Pancreatitis-vs-NoPancreatitis
8.295400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.909200E-01
Normal-vs-N1
5.064200E-01
N0-vs-N1
9.991400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.418400E-01
Normal-vs-TP53-NonMutant
6.308600E-01
TP53-Mutant-vs-TP53-NonMutant
1.257670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
